CoChat

The detrimental effects of smoking on the course and outcome in adults with bipolar disorder—A narrative review

Open access
Grunze, Anna, Mosolov, Sergey, Grunze, Heinz, Born, Christoph · 2023 · Frontiers in Psychiatry

The DOI matches its Crossref record; 91 of the 96 references it cites were found in a registry or an index; 53 of the 113 sources its claims cite were checked for support.

Abstract

Background: Smoking is a substantial and avoidable risk for physical disability and premature death. Despite a declining tobacco use in the community of developed countries, smoking remains abundant in people with mental disorders. This narrative review highlights the epidemiology, consequences and treatment options of tobacco use disorder (TUD) and nicotine dependence (ND) in people with bipolar disorder (BD). Methods: The authors conducted a Medline literature search from 1970 to November 2022 using MeSH terms “bipolar disorder” x “smoking” or “nicotine” or “tobacco” that retrieved 770 results. Search results were complemented by additional literature retrieved from examining cross references and by hand search in text books. Finally, 92 references were considered as essential and selected for the educational purpose of this review. Summary of findings: Lifetime and point prevalence of smoking in people with BD is in the range of 45–70% and thus about 2–3 times more frequent in BD than in community samples. Smoking, TUD and ND have a detrimental impact both on mental and physical health as well as mortality in people with BD. In the absence of large controlled studies in comorbid BD and TUD or ND, pharmacological treatment follows the individual guidance for each disorder. Community-based psychosocial interventions for TUD and ND appear to be suitable in people with BD, too, as well as Cognitive Behavioral (CBT) or Acceptance and Commitment (ACT) based psychotherapies. Conclusions: Smoking is a modifiable risk factor causing increased risks both for mental and physical health in BD, and deserves more attention in treatment. More treatment research into pharmacological and psychosocial interventions in comorbid BD and TUD or ND are still needed to deliver evidence-based recommendations to physicians. Copyright © 2023 Grunze, Mosolov, Grunze and Born.

Overview

CoChat Summary

## TL;DR

This narrative review concludes that smoking, tobacco use disorder (TUD), and nicotine dependence (ND) are about 2–3 times more common in adults with bipolar disorder (BD) than in community samples and are linked to worse mental health, physical health, and mortality. The paper also argues that evidence for smoking-cessation treatment in BD is limited, but bupropion, varenicline, nicotine replacement therapy (NRT), and psychosocial approaches such as CBT and ACT all show promise.

## Key findings

  • Lifetime and point prevalence of smoking in people with BD were reported to be in the 45–70% range, compared with 25–30% in the general population; the review also cites a pooled point prevalence of TUD/ND of 46.3% (95% CI 33.9–59.2%).
  • In the US National Comorbidity Survey, the lifetime prevalence of daily smoking among adults with BD was 59% versus 39.1% in adults without mental disorders; a Kentucky study reported 66% everyday current smoking in people with BD.
  • Smoking was associated with worse BD course and outcomes, including higher symptom load for mania, depression, and anxiety, more agitation and impulsivity, more hospitalizations, lower functionality, and more suicide attempts; in adolescents, 25% had ever smoked, 11% smoked daily, and half of daily smokers were heavy smokers (≥10 cigarettes/day).
  • A bidirectional Mendelian randomization study in 20,129 cases and 21,524 controls found smoking to be an underlying risk factor for BD: OR 1.46 for smoking initiation and OR 1.72 for lifetime smoking; conversely, there was no unambiguous evidence that BD causally influenced smoking-related outcomes.
  • For cessation treatment, the review identified only four published smoking-cessation treatment trials in smokers with BD; all were in favor of the specific treatment, and the paper notes limited evidence favoring bupropion, varenicline, or NRT.

## Methods

  • Narrative review based on a Medline search on November 12, 2022 using MeSH terms for “bipolar disorder” crossed with “smoking,” “nicotine,” or “tobacco,” yielding 770 results; additional references were found through cross-references and textbook hand search.
  • The authors selected 92 articles by consensus from the 770 references, prioritizing studies, reviews, meta-analyses, and opinion papers judged useful for educational purposes.
  • The review summarizes epidemiology, biological mechanisms, consequences for mental and physical health, and pharmacological/psychosocial treatment options for comorbid BD and TUD/ND.

## Limitations

  • The paper explicitly states it is “not a full and comprehensive review” and instead summarizes key studies and reviews according to the authors’ judgment.
  • It notes that definitions of BD and of tobacco-related diagnoses changed over time, and that many prevalence studies did not use validated structured interviews, which likely contributes to the wide range of reported prevalence, correlates, and odds.
  • Evident from the text: this is a narrative review, so its conclusions are limited by the underlying heterogeneous literature, and it reports that large controlled studies specifically in comorbid BD and TUD/ND are lacking.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fpsyt.2022.1114432

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Schematic and simplified representation of the action of nicotine on the mesocorticolimbic dopaminergic reward circuitry. After passing the brain-blood barrier, Inhaled nicotine stimulates the low affinity α7 and the high affinity α4β2 nicotinic receptors located in the ventral tegmental area (VTA) activating the reward circuitry. Dopaminergic and glutamatergic neurons project from the VTA to the core and shell of the nucleus accumbens (NAC), as well as to the prefrontal cortex (PFC), glutamatergic neurons from the PFC to the NAC, and GABAergic neurons from the NAC back to the VTA. Both hyperexcitation of the VTA, e.g., by nicotine, as well as lack of inhibition by GABAergic projections from the NAC can result in rapid dopamine release.
Figure 1 Schematic and simplified representation of the action of nicotine on the mesocorticolimbic dopaminergic reward circuitry. After passing the brain-blood barrier, Inhaled nicotine stimulates the low affinity α7 and the high affinity α4β2 nicotinic receptors located in the ventral tegmental area (VTA) activating the reward circuitry. Dopaminergic and glutamatergic neurons project from the VTA to the core and shell of the nucleus accumbens (NAC), as well as to the prefrontal cortex (PFC), glutamatergic neurons from the PFC to the NAC, and GABAergic neurons from the NAC back to the VTA. Both hyperexcitation of the VTA, e.g., by nicotine, as well as lack of inhibition by GABAergic projections from the NAC can result in rapid dopamine release.CC BY · PubMed Central

Verification

Claims the paper makes

39 Valid · 5 Not valid · 36 Not checked · 11 Own results and interpretations

50 more claims · 23 with their cited sources checked

Create a free account to see all 91 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 35
  • Probably not a substantial claim. 4

Create a free account to see these claims.

Citations

Cites

Research works printed but not linked: 2

  1. 2013, Diagnostic and Statistical Manual of Mental Disorders. 5th ed
  2. Trushchelev, 2019, Organizational and methodological aspects of the tobacco addiction treatment, Curr Ther Mental Disord., 4, 19

Cited by

See all 11

Metadata

Authors
Grunze, A., Mosolov, S., Grunze, H., & Born, C.
Affiliations
  • Russian Medical Academy of Continuous Professional Education (RU)
  • Paracelsus Medizinische Privatuniversität (DE)
Corresponding author
Grunze, Heinz
Venue
Frontiers in Psychiatry
Published
2023-01-09
Volume
13
Pages
1114432-1114432
ISSN
1664-0640 (ISSN-L)
OpenAlex
W4313823871
Cited by
11
References
96
Citations by year
2026: 6 · 2025: 2 · 2024: 1 · 2023: 2
FWCI
0.39
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
bipolar disorder, smoking, tobacco use disorder, nicotine dependence, comorbidities, smoking prevalence, mortality, physical health, mental health, psychosocial interventions, cognitive behavioral therapy, acceptance and commitment therapy, pharmacotherapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.